DCF — NORTH HOUSTON SURGICAL HOSPITAL
Enterprise Value: $9.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$9.0M
Enterprise Value
$1.1M
PV of Cash Flows
$7.9M
PV of Terminal Value
$12.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $61.8M | $2.4M | 4.0% | $-0.5M | $-0.4M |
| Year 2 | $63.7M | $3.1M | 5.0% | $0.0M | $0.0M |
| Year 3 | $65.6M | $3.8M | 6.0% | $0.5M | $0.4M |
| Year 4 | $67.6M | $4.3M | 6.0% | $0.8M | $0.5M |
| Year 5 | $69.6M | $4.6M | 7.0% | $0.9M | $0.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $9.0M. Terminal value accounts for 88% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$60.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03338006592423557
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5